@article{oai:nagoya.repo.nii.ac.jp:00028748,
 author = {Muramatsu, Tomoaki and Funahashi, Yasuhito and Yamamoto, Akiyuki and Sassa, Naoto and Matsukawa, Yoshihisa and Gotoh, Momokazu},
 issue = {4},
 journal = {Nagoya Journal of Medical Science},
 month = {Nov},
 note = {Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report shows that conventional alternative antiandrogens are cost effective and are still an important option for the treatment for CRPC.},
 pages = {707--710},
 title = {A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure},
 volume = {81},
 year = {2019}
}